Advances and applications of organoids: a review.
- Author:
Donghong YU
1
;
Hua CAO
2
;
Xinrui WANG
2
Author Information
- Publication Type:Review
- Keywords: disease model; organoids; pharmaceutical research; precision medicine; regenerative medicine; stem cells
- MeSH: Gene Editing; Humans; Models, Biological; Organoids; Regenerative Medicine; Stem Cells
- From: Chinese Journal of Biotechnology 2021;37(11):3961-3974
- CountryChina
- Language:Chinese
- Abstract: Novel model systems have provided powerful tools for the research of human biology. Despite of being widely used, the conventional research models could not precisely describe the human physiological phenomenon. Organoids are three-dimensional multicellular aggregates derived from stem cells or organ progenitors that could differentiate and self-organize to recapitulate some specific functionalities and architectures of their in vivo counterpart organs. Organoids can be used to simulate organogenesis because of their human origin. In addition, the genomic stability of organoids could be well maintained during long-term amplification in vitro. Moreover, organoids can be cryopreserved as a live biobank for high-throughput screening. Combinatorial use of organoids with other emerging technologies (e.g. gene editing, organ-on-a-chip and single-cell RNA sequencing) could overcome the bottlenecks of conventional models and provide valuable information for disease modelling, pharmaceutical research, precision medicine and regenerative medicine at the organ level. This review summarizes the classifications, characteristics, current applications, combined use with other technologies and future prospects of organoids.
